check_circleStudy Completed
Ischemia, Cerbral
Bayer Identifier:
Trial_0178
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Cerebral blood flow (CBF) with 40, 60 and 80 mg of Nimodipine.
Trial purpose
Please see attached Study Results Summary below
Key Participants Requirements
Sex
N/AAge
17 - 67 YearsTrial summary
Enrollment Goal
48Trial Dates
January 1982 - December 1982Phase
N/ACould I Receive a placebo
N/AProducts
Nimotop (Nimodipine, BAYE9736)Accepts Healthy Volunteer
N/ATrial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A